• LDS
  • /Medical Tests
  • /UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome)

Diseases (1)
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Overview
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Clinical Utility
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Interpretation
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Reference Ranges
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Methodology
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Specimen Collection
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Additional Testing
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Turnaround Time
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

CPT
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

LOINC
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

ICD10
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Additional ICD10
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

References
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.

Panel Test Components
Access to UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome) is restricted.